Does inhibition of p38 mitogen-activated protein kinase reduce inflammation after coronary vascular injury in humans?
In the setting of statin therapy, SB-681323 significantly attenuated the post-PCI inflammatory response, as measured by hsCRP. This inflammatory dampening implicates p38 mitogen-activated protein kinase in the poststent response, potentially defining an avenue to limit poststent restenosis.
These motor cortical findings may not be directly applicable to prefrontal rTMS.